Hyaluronidase-Functionalized Silica Nanocarrier for Enhanced Chemo-Immunotherapy through Inducing Immunogenic Cell Death
Authors:
- 16 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (5) , 3378-3389
Abstract
The chemo-immunotherapy has become a highly prospective method for cancer treatment and it has been known that chemotherapeutic drugs (e.g., doxorubicin (DOX)) could trigger antitumor immune responses. Yet, insufficient tumor penetrability and weak immunogenic cell death (ICD) severely limits the therapeutic effect of chemo-immunotherapy against cancer. Herein, we report the design of DOX loaded silica nanocarriers ([email protected]) with hyaluronidase functionalization, which could increase the permeability of drug and induce enhanced ICD effect through degradation of hyaluronic acid (HA) in the extracellular matrix (ECM). Interestingly, the controlled release of DOX from [email protected] in the acidic microenvironment induced ICD of tumor cells to release tumor antigens and damage-associated molecular patterns, promoting the antigen-presentation of dendritic cells (DCs) and the activation of specific tumor immunity. Moreover, HMSPHs could be used as an immune adjuvant to promote maturation of DCs, thereby promoting the activation of tumor infiltrating cytotoxic T lymphocytes. This strategy presents a concept to improve the efficacy of chemo-immunotherapy through degradation of HA in the ECM.Keywords
Funding Information
- National Natural Science Foundation of China (81972565)
- Program for HUST Academic Frontier Youth Team (2015-01)
This publication has 39 references indexed in Scilit:
- ATP release and purinergic signaling in NLRP3 inflammasome activationFrontiers in Immunology, 2013
- Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymersBiomaterials, 2013
- Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancerInternational Journal of Cancer, 2012
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- CD91-dependent programming of T-helper cell responses following heat shock protein immunizationNature Communications, 2011
- ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursorsProceedings of the National Academy of Sciences, 2011
- The purinergic receptor P2Y2receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammationAllergy, 2010
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the PhagocyteCell, 2005
- Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4Journal of Experimental Medicine, 2002